Skip to main content
Log in

Mechanism and significance of abnormal blood level of β2-microglobulin in patients with Graves’ disease

  • Published:
Journal of Tongji Medical University Aims and scope Submit manuscript

Summary

The blood-level of β2-microglobulin (β2-mG) in patients with Graves disease is generally elevated, varying with the condition of the patients. After treatment with Tapazole, the blood level of β2-mG is gradually lowered to normal range with improvement of the disease. In this study the mechanism and significance of such variations of β2-mG in Graves disease patients were investigated by observing suppressor T-lymphocyte function (expressed as suppression index, SI). At the same time the blood levels of β2-mG of the same subjects were determined. It was found that the quantitative variation of the blood β2-mG was related to the condition of patients as well as to the status of immunologic system. The high level of blood β2-mG was probably due to the dysfunction of suppressor T-lymphocytes. The measurement of blood β2-mG was much easier than that of SI, and possibly, the former could be used instead of the latter to show the function of cell-mediated immunity in patients with Graves disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Poulik MD, et al. Eeta 2-microglobulin production and secretion by lymphocytes in culture. J Immunol 1973; 110: 1430–3.

    PubMed  CAS  Google Scholar 

  2. Bach ML, et al. Beta 2-microglobulin: association with lymphocyte receptors. Science 1973; 182: 1350–2.

    Article  PubMed  CAS  Google Scholar 

  3. Goodwin JS, et al. Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol 1980; 15: 106–22.

    Article  PubMed  CAS  Google Scholar 

  4. Stenson WF, et al. Prostaglandins, macrophages, and immunity. J Immunol 1980; 125: 1–5.

    PubMed  CAS  Google Scholar 

  5. Pacini F, et al. Effect of indomethacin on phytohemagglutinin-stimulated peripheral blood lymphocytes in thyroid autoimmune diseases. J Clin Immunol 1982; 2: 335–42.

    Article  PubMed  CAS  Google Scholar 

  6. How J, et al. T lymphocyte sensitization and suppressor T lymphocyte defect in patients long after treatment for Graves disease. Clin Endocrin 1983; 18: 61–71.

    Article  CAS  Google Scholar 

  7. Bene MC, et al. Graves disease in situ localization of lymphoid T cell subpopulation. Clin Exp Immunol 1983; 52: 311–6.

    PubMed  CAS  Google Scholar 

  8. Bhalla RB, et al. Abnormally high concentrations of beta 2-microglobulin in acquired immunodeficiency syndrome (AIDS) patients. Clin Chem 1983; 29: 1560.

    PubMed  CAS  Google Scholar 

  9. Simonsson B, et al. Eeta 2-microglobulin in chronic lymphocytic leukemia. Scand J Haematol 1980; 24: 174–80.

    PubMed  CAS  Google Scholar 

  10. Volpe R. The pathogenesis of Graves disease: an overview. Clin Endocrinol Metabol 1978; 7: 3–29.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xiao-liang, H., Wei-xin, Y. Mechanism and significance of abnormal blood level of β2-microglobulin in patients with Graves’ disease. Journal of Tongji Medical University 8, 35–40 (1988). https://doi.org/10.1007/BF02887775

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02887775

Key words

Navigation